Sign in
Not yet taking people in United StatesNo phase

Immune Dysregulation During Sepsis: A Natural History Cohort

Key facts

Who runs it
National Heart, Lung, and Blood Institute (NHLBI)
Where
Falls Church, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
500 people, planned
Starts
1 Jan 2027
Expected to end
31 Jan 2037
Type of study
Observational
Record updated
9 October 2026

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who cannot take part

  • Currently receiving infusion of epinephrine; or dopamine at an infusion rate of > 2.5; microgram/kg/min, norepinephrine of > 20 mircogram/min, or vasopressin > 0.04 units/min
  • Baseline cognitive impairment
  • Hemoglobin < 7 microgram/dL at the time of enrollment
  • Hemoglobin <10 microgram/dL in patients with known coronary artery disease or active EKG changes consistent with acute ischemia
  • Neutropenia (absolute neutrophil count less than 1000 cells/microliter)
  • Any individual who meets any of the following criteria will be excluded from participation in this study:
  • Pregnancy

Other criteria

  • INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Age >= 18 years old
  • Admitted to INOVA Fairfax Hospital
  • Meets sepsis-3 definition of sepsis in the last 48 hours; Suspected infection; Evidence of organ dysfunction (SOFA score >= 2)
  • Ability of subject or LAR to understand and the willingness to sign a written informed consent document

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 100 years old?

Where in United States

  • Inova Fairfax HospitalFalls Church, United StatesContact: Chris KingNot yet recruiting

About the trial

What the trial wants to find out

Background:

Read full original descriptionShow less

Sepsis is an illness that occurs when the body s immune system runs out of control. This can damage organs. Sepsis causes an estimated 1 in 5 deaths worldwide. In this natural history study, researchers want to learn more about how the immune system changes during sepsis. They hope this knowledge will help them find better ways to treat sepsis.

Objective:

To understand how sepsis affects the body over time.

Eligibility

People aged 18 years and older admitted to INOVA Fairfax Hospital in Virginia and who have sepsis.

Design:

Researchers will collect data from participants medical records.

Participants will have blood drawn at least 5 times while they are in the hospital. Blood may be collected for up to 30 days, if they remain in the hospital that long. The blood will be taken from access lines that are already in place. Some blood draws will be optional.

Participants may opt to have up to 3 tests of their heart function while they are in the hospital.

Some participants may have a sample of fluid collected from their lungs.

Participants will have a follow-up visit about 90 days after they join the study. This visit will be by phone call if they have left the hospital. They will fill out a questionnaire. They will answer questions about their health and how they feel. The call will last about 30 minutes.

The group in the trial

  • Participants with Sepsis

    Sepsis

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07735741, who can take part
Record updated
9 October 2026